NCLAT: IRP Has Authority to Take Possession of Assets Owned by Corporate Debtor  ||  NCLAT: NCLT Can Direct Forwarding a Copy of its Order to Relevant Statutory Authorities  ||  Delhi HC: Centre to Expedite Process of Accessibility Features in OTT platforms for PwDs  ||  Delhi HC: Once Worker Provides Testimony Under Oath ‘Burden of Proof’ Shifts on Employer  ||  SC: There Cannot be Discrimination in Matter of Payment of Pension to Retired Judges  ||  SC: India is Not a Dharamshala that Can Entertain Foreign Nationals from All Over  ||  SC: Can Quash Domestic Violence Act Complaints Under Section 482 of CrPC  ||  Supreme Court: Can’t Use Statement of One Accused against Another  ||  SC: Inclusion of Name in Draft NRC Cannot Annul Foreigners Tribunal’s Declaration as Non-Citizen  ||  Supreme Court: Minimum Practice of 3 Years Mandatory to Enter Judicial Service    

Delhi HC Seeks Centre's Response on How It Intends to Obtain Supply of Tocilizumab Drug - (17 May 2021)

CIVIL

Delhi High Court has sought Centre's response on the demand of Tocilizumab drug and how does the Centre intend to obtain the supplies of the said drug through Roche India and other global manufacturers, observing that no assurance was given by Roche India, which enjoys the license of manufacturing Tocilizumab 400 mg, if any further stock can be supplied to India.

Tags : DELHI HIGH COURT   SUPPLY OF TOCILIZUMAB DRUG  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved